 |
|
|
| |
The Increased Mortality and the Medicare Disability Eligibility Status of the HCV Population in the US
|
| |
| |
" Medicare beneficiaries with HCV have almost 5 times the annual mortality of non-diagnosed beneficiaries" from Jules: and the care costs for last year of life are high - $100,000 - which is much higher than treatment cost - therefore all should be identified and treated early
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Gabriela Dieguez1, Bruce Pyenson1, Steven E Marx2, Yuri Sanchez Gonzalez2
1 Milliman Inc.
2 AbbVie Inc.
|
| |
|
|
|
|
|
